Eric Fader authored a chapter in the 2015 edition of Westlaw's "Data Security and Privacy Law" treatise, published by Thomson Reuters. Mr. Fader edited the "Health Care Privacy and the Health Insurance Portability and Accountability Act of 1996" chapter of the treatise, which he had previously rewritten for the 2014 edition to incorporate major changes to HIPAA rules in 2013.
On January 30, Jed Davis will speak at The Knowledge Group Webcast, "Best Strategies in Protecting Your Firm Against Hackers: What Hackers Can and Cannot Do?"
Theresa Kelly and Howard Fetner wrote an article, "AARP Lawsuit Puts EEOC In An Awkward Position," for Law360.
Jed Davis authored the article, "Cybersecurity for the Under-Resourced" for Bloomberg BNA.
On November 2, Susan Huntington and Eric Fader will be speaking at a webinar jointly sponsored by Day Pitney and Wolf & Co. "Business Associates Are Under a Microscope - Are You Prepared?"
On August 30, Susan Huntington was a speaker in the webcast "Medical Devices in Hospital Networks: Mitigating Risk in 2016" hosted by the Knowledge Group.
Eric Fader was quoted in an article, "Trump Era Likely Will Increase Collections From Patients But End MACRA," in Part B News. In the article, Fader discussed how an alternative plan for national health care reform offered by Speaker of the House Paul Ryan, called "A Better Way," might gain support if the Affordable Care Act (ACA) is repealed, in whole or in part.
Eric Fader was quoted in an article, "Unknown Future of ACA Puts Blues Plans In an Uncomfortable Spot Heading Into '17," published in The AIS Report on Blue Cross and Blue Shield Plans.
Eric Fader was quoted in an article, "Trump may maintain support for health IT, cut funds for HIPAA audits," in McKnight's Long Term Care News.
Eric Fader was quoted in an article, "Incoming Trump Administration May Mean Less Funding for HIPAA Audits," in Bloomberg BNA’s Health Care Fraud Report.
Eric Fader was quoted in an article, "Prior Defects Could Sink Auvi-Q Even As EpiPen Prices Soar," in Law360. In the article, Fader points out that with lawmakers and consumers calling for a competitor to challenge Mylan NV in the aftermath of the drugmaker's EpiPen price increases, potential competitor Kaléo Pharma has a "golden opportunity" with its updated version of the Auvi-Q epinephrine injector.